CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 47 filers reported holding CIDARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,270 | -98.8% | 1,000 | -99.5% | 0.00% | -100.0% |
| Q2 2022 | $102,000 | -95.1% | 208,443 | -91.7% | 0.05% | -94.5% |
| Q1 2022 | $2,079,000 | -29.2% | 2,496,520 | +8.0% | 0.86% | -36.0% |
| Q4 2021 | $2,936,000 | +67.4% | 2,311,530 | +195.3% | 1.35% | +68.8% |
| Q3 2021 | $1,754,000 | -28.3% | 782,817 | -35.4% | 0.80% | -37.7% |
| Q2 2021 | $2,447,000 | -24.3% | 1,211,286 | -7.0% | 1.28% | -62.5% |
| Q1 2020 | $3,231,000 | +11.9% | 1,302,981 | +98.6% | 3.42% | +102.4% |
| Q3 2018 | $2,887,000 | +30.5% | 656,148 | +54.2% | 1.69% | +25.5% |
| Q2 2018 | $2,213,000 | – | 425,531 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |